Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) reported Q1 EPS of ($0.38), $0.05 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $3.83 million versus the consensus estimate of $2.67 million.

For earnings history and earnings-related data on Verrica Pharmaceuticals Inc. (VRCA) click here.